Thamer C - Search Results

1

Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease.

Frölich L, Wunderlich G, Thamer C, Roehrle M, Garcia M Jr, Dubois B. Frölich L, et al. Among authors: thamer c. Alzheimers Res Ther. 2019 Feb 12;11(1):18. doi: 10.1186/s13195-019-0467-2. Alzheimers Res Ther. 2019. PMID: 30755255 Free PMC article. Clinical Trial.

2

Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial.

Ross S, Thamer C, Cescutti J, Meinicke T, Woerle HJ, Broedl UC. Ross S, et al. Among authors: thamer c. Diabetes Obes Metab. 2015 Jul;17(7):699-702. doi: 10.1111/dom.12469. Epub 2015 May 13. Diabetes Obes Metab. 2015. PMID: 25827441 Clinical Trial.

3

Reduced skeletal muscle oxygen uptake and reduced beta-cell function: two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes.

Thamer C, Stumvoll M, Niess A, Tschritter O, Haap M, Becker R, Shirkavand F, Bachmann O, Rett K, Volk A, Häring H, Fritsche A. Thamer C, et al. Diabetes Care. 2003 Jul;26(7):2126-32. doi: 10.2337/diacare.26.7.2126. Diabetes Care. 2003. PMID: 12832324

4

Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion.

Heni M, Ketterer C, Thamer C, Herzberg-Schäfer SA, Guthoff M, Stefan N, Machicao F, Staiger H, Fritsche A, Häring HU. Heni M, et al. Among authors: thamer c. Diabetes. 2010 Dec;59(12):3247-52. doi: 10.2337/db10-0674. Epub 2010 Aug 29. Diabetes. 2010. PMID: 20802253 Free PMC article.

5

Multiple symmetric lipomatosis: a paradigm of metabolically innocent obesity?

Haap M, Siewecke C, Thamer C, Machann J, Schick F, Häring HU, Szeimies RM, Stumvoll M. Haap M, et al. Among authors: thamer c. Diabetes Care. 2004 Mar;27(3):794-5. doi: 10.2337/diacare.27.3.794. Diabetes Care. 2004. PMID: 14988304 No abstract available.

6

Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes.

Haupt A, Thamer C, Heni M, Ketterer C, Machann J, Schick F, Machicao F, Stefan N, Claussen CD, Häring HU, Fritsche A, Staiger H. Haupt A, et al. Among authors: thamer c. Diabetes. 2010 Mar;59(3):747-50. doi: 10.2337/db09-1050. Epub 2009 Dec 22. Diabetes. 2010. PMID: 20028944 Free PMC article.

7

The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations.

Stumvoll M, Fritsche A, t'Hart LM, Machann J, Thamer C, Tschritter O, Van Haeften TW, Jacob S, Dekker JM, Maassen JA, Machicao F, Schick F, Heine RJ, Häring H. Stumvoll M, et al. Among authors: thamer c. Exp Clin Endocrinol Diabetes. 2004 May;112(5):253-7. doi: 10.1055/s-2004-817972. Exp Clin Endocrinol Diabetes. 2004. PMID: 15146371

8

Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids.

Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J, Fritsche A, Schick F, Häring H, Stumvoll M. Thamer C, et al. Horm Metab Res. 2005 Apr;37(4):246-51. doi: 10.1055/s-2005-861411. Horm Metab Res. 2005. PMID: 15952086 Clinical Trial.

9

Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.

Thamer C, Haap M, Heller E, Joel L, Braun S, Tschritter O, Haring H, Fritsche A. Thamer C, et al. Horm Metab Res. 2006 Mar;38(3):178-82. doi: 10.1055/s-2006-925204. Horm Metab Res. 2006. PMID: 16673209

10

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.

Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Häring H, Stumvoll M. Tschritter O, et al. Among authors: thamer c. Diabetes. 2003 Feb;52(2):239-43. doi: 10.2337/diabetes.52.2.239. Diabetes. 2003. PMID: 12540592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page